AAAAAA
Results:
1-9
|
Results: 9
Authors:
Huang, Q
Dunn, RT
Jayadev, S
DiSorbo, O
Pack, FD
Farr, SB
Stoll, RE
Blanchard, KT
Citation: Q. Huang et al., Assessment of cisplatin-induced nephrotoxicity by microarray technology, TOXICOL SCI, 63(2), 2001, pp. 196-207
Authors:
Thompson, KL
Rosenzweig, BA
Honchel, R
Cannon, RE
Blanchard, KT
Stoll, RE
Sistare, FD
Citation: Kl. Thompson et al., Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA, MOL CARCINO, 32(4), 2001, pp. 176-186
Authors:
Honchel, R
Rosenzweig, BA
Thompson, KL
Blanchard, KT
Furst, SM
Stoll, RE
Sistare, FD
Citation: R. Honchel et al., Loss of palindromic symmetry Tg.AC mice with a nonresponder phenotype, MOL CARCINO, 30(2), 2001, pp. 99-110
Authors:
Tennant, R
Haseman, J
Stoll, RE
Citation: R. Tennant et al., Transgenic assays and the identification of carcinogens, ENV MOL MUT, 37(1), 2001, pp. 86-88
Authors:
Stoll, RE
von Linde, F
Citation: Re. Stoll et F. Von Linde, Hydrogen - what are the costs?, HYDROC PROC, 79(12), 2000, pp. 42
Authors:
Hamlin, RL
Nakayama, T
Brady, JT
Stoll, RE
Citation: Rl. Hamlin et al., Hemodynamic and electrophysiologic effects of ontazolast in dogs, AM J VET RE, 61(11), 2000, pp. 1364-1368
Authors:
Holden, HE
Stoll, RE
Blanchard, KT
Citation: He. Holden et al., Oxymetholone: II. Evaluation in the Tg.AC transgenic mouse model for detection of carcinogens, TOX PATHOL, 27(5), 1999, pp. 507-512
Authors:
Stoll, RE
Holden, HE
Barthel, CH
Blanchard, KT
Citation: Re. Stoll et al., Oxymetholone: III. Evaluation in the p53(+/-) transgenic mouse model, TOX PATHOL, 27(5), 1999, pp. 513-518
Authors:
Blanchard, KT
Barthel, C
French, JE
Holden, HE
Moretz, R
Pack, FD
Tennant, RW
Stoll, RE
Citation: Kt. Blanchard et al., Transponder-induced sarcoma in the heterozygous p53(+/-) mouse, TOX PATHOL, 27(5), 1999, pp. 519-527
Risultati:
1-9
|